1-2 of 2
Amelie Anota
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

Health-Related Quality of Life after Axi-Cel As a Second-Line Therapy in Patients with High-Risk Relapsed/Refractory Large B-Cell Lymphoma Who Are Ineligible for Autologous Stem Cell Transplantation: Results of the Alycante Phase II Trial

Emilie Charton, Amelie Anota, Emmanuel Bachy, Guillaume Cartron, François-Xavier Gros, Franck Morschhauser, Lucie Oberic, Thomas Gastinne, Pierre Feugier, Remy Dulery, Catherine Thieblemont, Magalie Joris, Fabrice Jardin, Sylvain Choquet, Olivier Casasnovas, Gabriel Brisou, Morgane Cheminant, Jacques-Olivier Bay, Francesco Llamas Gutierrez, Cédric Portugues, Emmanuel Itti, Xavier Pallard, Paul Blanc-Durand, Yassine Al Tabaa, Clément Bailly, Camille Laurent, Francois Lemonnier, Roch Houot
Journal: Blood
Blood (2024) 144 (Supplement 1): 4505.
https://doi.org/10.1182/blood-2024-200614
Published: 2024
Journal Articles

Inclusion of Patient's Self-Reported Fatigue into a Standard Laboratory Risk Classification Enhances Survival Prediction in Patients with Advanced Myelodysplastic Syndromes

Fabio Efficace, PhD, Pasquale Niscola, MD, Francesco Cottone, Gianluca Gaidano, MD PhD, Amelie Anota, Franck Bonnetain, Giovanni Caocci, MD, Luana Fianchi, Massimo Breccia, MD, Reinhard Stauder, MD, Uwe Platzbecker, MD, Giuseppe A Palumbo, Mario Luppi, MD, PhD, Rosangela Invernizzi, Micaela Bergamaschi, MD, Marilena Fedele, Anna Angela Di Tucci, Huiyong Zhang, Marco Vignetti, MD, Franco Mandelli, MD
Journal: Blood
Blood (2016) 128 (22): 1242.
https://doi.org/10.1182/blood.V128.22.1242.1242
Published: 2016